Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
|
|
EAGLE PHARMACEUTICALS, INC. (EGRX)
|
|
| Credit Analysis |
|
|
|
|
Annual | Quarterly |
|
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| | Source | Source | Source | Source | Source | Source | Source | Source |
| Short-term debt | 6.3 | 25.6 | 8.0 | 5.0 | 6.3 | 4.9 | | |
| Long-term debt | 56.2 | | 25.1 | 33.6 | 38.2 | 42.9 | | |
| Total debt | 62.5 | 25.6 | 33.1 | 38.6 | 44.4 | 47.8 | | |
| Net debt | 7.1 | | | | | | | |
| |
| Debt to EBITDA | 0.7 | 3.9 | 0.9 | 1.5 | 0.9 | 0.6 | 0.0 | 0.0 |
| Net debt to EBITDA | 0.1 | | | | | | | |
| |
| EBITDA interest coverage | 23.0 | 4.0 | 14.2 | 9.4 | 18.3 | 69.8 | 6,768.4 | 242.9 |
| EBIT interest coverage | 20.0 | 1.7 | 12.8 | 8.1 | 17.0 | 66.5 | 6,569.8 | 232.7 |
|